Migraine and Headache are costing the world economy 155 billion euro's per year. Medication seems to be the first therapy choice, although Biofeedback cab be an excellent way of treating these conditions, without using medication and with long-lasting effects.
47% of adults have a headache disorder
190 million working days lost per year in EU due to migraine
Headaches and migraines are under-recognised and under-diagnosed and it is costing the world's economy £140billion a year, says the World Health Organisation. Almost half of all adults worldwide suffer headache disorders and the burdens they impose on society must be improved, the WHO said. Publishing its first global atlas on headaches, the Geneva-based United Nations health body said it found that 47 per cent of all adults have a headache disorder and 'the financial costs to society through lost productivity are enormous.' In the European Union alone, 190 million days are lost from work every year because of migraine, it said.
'Headache and migraine disorders are greatly underrated and underreported by health systems and receive too little attention,' said Dr Shekhar Saxena, the WHO's director of mental health and substance abuse disorders. 'Headaches can be debilitating for many people, rendering them unable to work.'During migraine attacks, 90 per cent of people postpone household chores, almost three-quarters have limited ability to work and half of them miss work entirely.'
Migraines affect around one in six women and one in 12 men, and have been estimated to be the most expensive brain disorder to society in the EU and the United States.The WHO report found that, most importantly, headache disorders are very disabling: Worldwide, migraines alone are the cause of 1.3 per cent of all disability due to illness, it said, and experts estimate that taken together, all headache disorders account for double this burden.
Migraines alone are the cause of an estimated 400,000 lost days from work or school every year per million of the population in developed countries, and in the EU, the total annual cost of all headaches was recently estimated at 155 billion euros (approximately £140billion).
'Governments must take the issue more seriously, train health personnel in headache disorder diagnosis and treatment, and ensure appropriate medication is available and used properly,' said Dr Saxena. An international scientific team said last year it had for the first time identified a genetic risk factor linked with common migraines - a finding that could open the way for new treatments to prevent migraine attacks.